\-\ Texto\\:\\ \ \(0\)\
\-\ \\'enlarged\\ liver\\'\\ \\-\\ otherwise\\ unremarkable\ \(0\)\
\-\ no\\ clinical\\ evidence\\ of\\ hypertension\ \(0\)\
\-\ cbc\\ \\-\\ within\\ normal\\ limits\ \(0\)\
\-\ serum\\ and\\ urine\\ metanephrines\\ \\-\\ within\\ normal\\ limits\ \(0\)\
\-\ 24\\-hour\\ urine\\ \\-\\ within\\ normal\\ limits\ \(0\)\
\-\ further\\ evaluation\\ is\\ underway\\ to\\ determine\\ exact\\ subtype\\ of\\ b\\-cell\\ lymphoma\\ prior\\ to\\ initiation\\ of\\ treatment\\.\ \(0\)\
\-\ 10\\ cm\\ abdominal\\ enhancing\\ mass\\ superior\\ to\\ right\\ kidney\\,\\ with\\ internal\\ flow\\ on\\ ultrasound\\,\\ distinct\\ from\\ adrenal\\ gland\\.\\ \\ no\\ abdominal\\ or\\ pelvic\\ lymphadenopathy\\.\ \(0\)\
\-\ non\\-hodgkin\\'s\\ lymphoma\\ \\-\\ b\\-cell\\ lymphoma\ \(0\)\
\-\ pancreatic\\ carcinoma\ \(8\)\
\-\ pheochromocytoma\ \(23\)\
\-\ lymphoma\ \(373\)\
\-\ 60\\ year\\-old\\ man\\ with\\ enlarged\\ liver\\ by\\ physical\\ exam\\.\ \(1\)\
\-\ initial\\ biopsy\\ revealed\\ that\\ the\\ tumor\\ cells\\ are\\ strongly\\ positive\\ for\\ cd20\\ and\\ focally\\ positive\\ for\\ cd99\\;\\ but\\ negative\\ for\\ cytokeratin\\,\\ s100\\,\\ and\\ mesenchymal\\ markers\\ consistent\\ with\\ atypical\\ b\\-cell\\ lymphoma\\.\ \(0\)\
\-\ follow\\-up\\ flow\\ cytometry\\ revealed\\ that\\ predominant\\ cell\\ population\\ are\\ b\\-cells\\ expressing\\ cd45\\,\\ cd20\\ \\(bright\\)\\,\\ cd19\\,\\ cd10\\,\\ fmc\\-7\\ and\\ cd38\\.\\ \\ the\\ kappa\\ to\\ lambda\\ ratio\\ is\\ greater\\ than\\ 1\\:100\\,\\ lambda\\ light\\ chain\\ restricted\\.\\ \\ they\\ are\\ negative\\ for\\ cd34\\,\\ cd5\\,\\ and\\ cd23\\.\\ differential\\ diagnosis\\ includes\\ diffuse\\ large\\ b\\-cell\\ lymphoma\\ and\\ burkitt\\'s\\ lymphoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lymphoma\\:\\ 0\\.33556314462301334\ \(0\)\
\-\ cell\\:\\ 0\\.23022384703758594\ \(0\)\
\-\ cd20\\:\\ 0\\.21499989624176213\ \(0\)\
\-\ lambda\\:\\ 0\\.21499989624176213\ \(0\)\
\-\ limits\\:\\ 0\\.19080482201851753\ \(0\)\
\-\ urine\\:\\ 0\\.14410017279082823\ \(0\)\
\-\ underway\\:\\ 0\\.1287232161943462\ \(0\)\
\-\ expressing\\:\\ 0\\.1287232161943462\ \(0\)\
\-\ cells\\:\\ 0\\.1240349215464888\ \(0\)\
\-\ cd99\\:\\ 0\\.12300190510871989\ \(0\)\
\-\ s100\\:\\ 0\\.12300190510871989\ \(0\)\
\-\ cd45\\:\\ 0\\.12300190510871989\ \(0\)\
\-\ cd38\\:\\ 0\\.12300190510871989\ \(0\)\
\-\ cd34\\:\\ 0\\.12300190510871989\ \(0\)\
\-\ cd23\\:\\ 0\\.12300190510871989\ \(0\)\
\-\ metanephrines\\:\\ 0\\.11579390559006661\ \(0\)\
\-\ cd19\\:\\ 0\\.11579390559006661\ \(0\)\
\-\ kappa\\:\\ 0\\.11579390559006661\ \(0\)\
\-\ cd5\\:\\ 0\\.11579390559006661\ \(0\)\
\-\ within\\:\\ 0\\.11121552242412955\ \(0\)\
\-\ liver\\:\\ 0\\.11105332815906703\ \(0\)\
\-\ cd10\\:\\ 0\\.11104611768207998\ \(0\)\
\-\ enlarged\\:\\ 0\\.1097440711784872\ \(0\)\
\-\ cytometry\\:\\ 0\\.10916192438992128\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.10749994812088107\ \(0\)\
\-\ flow\\:\\ 0\\.10722588125599208\ \(0\)\
\-\ positive\\:\\ 0\\.10607935168869403\ \(0\)\
\-\ revealed\\:\\ 0\\.10555551337841446\ \(0\)\
\-\ initiation\\:\\ 0\\.10466838641174955\ \(0\)\
\-\ burkitt\\:\\ 0\\.10466838641174955\ \(0\)\
\-\ and\\:\\ 0\\.09979533116771158\ \(0\)\
\-\ negative\\:\\ 0\\.09966330801363017\ \(0\)\
\-\ normal\\:\\ 0\\.09859225425058817\ \(0\)\
\-\ for\\:\\ 0\\.0975852603521461\ \(0\)\
\-\ subtype\\:\\ 0\\.09488774050953708\ \(0\)\
\-\ focally\\:\\ 0\\.09426050438764544\ \(0\)\
\-\ mesenchymal\\:\\ 0\\.09426050438764544\ \(0\)\
\-\ chain\\:\\ 0\\.09426050438764544\ \(0\)\
\-\ markers\\:\\ 0\\.09308394908357451\ \(0\)\
\-\ are\\:\\ 0\\.09162843725903512\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.09098967018353814\ \(0\)\
\-\ predominant\\:\\ 0\\.09051130270001531\ \(0\)\
\-\ exact\\:\\ 0\\.08833616117558787\ \(0\)\
\-\ abdominal\\:\\ 0\\.08804572571174822\ \(0\)\
\-\ distinct\\:\\ 0\\.08543148795916165\ \(0\)\
\-\ strongly\\:\\ 0\\.08096781346163912\ \(0\)\
\-\ ratio\\:\\ 0\\.08073065679780284\ \(0\)\
\-\ to\\:\\ 0\\.08049073289955458\ \(0\)\
\-\ population\\:\\ 0\\.07615185880591246\ \(0\)\
\-\ determine\\:\\ 0\\.07485342711645902\ \(0\)\
\-\ adrenal\\:\\ 0\\.07454666526677833\ \(0\)\
\-\ bright\\:\\ 0\\.07338225324171832\ \(0\)\
\-\ pancreatic\\:\\ 0\\.07296923382430032\ \(0\)\
\-\ serum\\:\\ 0\\.07217778400304498\ \(0\)\
\-\ that\\:\\ 0\\.06986046800907848\ \(0\)\
\-\ light\\:\\ 0\\.06971244223804447\ \(0\)\
\-\ restricted\\:\\ 0\\.0691838977012004\ \(0\)\
\-\ cbc\\:\\ 0\\.06715775956071772\ \(0\)\
\-\ atypical\\:\\ 0\\.06603523299913325\ \(0\)\
\-\ gland\\:\\ 0\\.0653863605489444\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.06507278121424655\ \(0\)\
\-\ pelvic\\:\\ 0\\.0629198085700112\ \(0\)\
\-\ includes\\:\\ 0\\.06259087784013843\ \(0\)\
\-\ hypertension\\:\\ 0\\.0615870421066097\ \(0\)\
\-\ 60\\:\\ 0\\.060203683154834015\ \(0\)\
\-\ greater\\:\\ 0\\.05929987778836568\ \(0\)\
\-\ they\\:\\ 0\\.05751257539652\ \(0\)\
\-\ otherwise\\:\\ 0\\.057377113658505244\ \(0\)\
\-\ kidney\\:\\ 0\\.056548129407575316\ \(0\)\
\-\ biopsy\\:\\ 0\\.05642157708539127\ \(0\)\
\-\ internal\\:\\ 0\\.05424643556096383\ \(0\)\
\-\ initial\\:\\ 0\\.053996685866983536\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05396136547472461\ \(0\)\
\-\ further\\:\\ 0\\.052425376554621005\ \(0\)\
\-\ no\\:\\ 0\\.052349752236315286\ \(0\)\
\-\ superior\\:\\ 0\\.05233078074107825\ \(0\)\
\-\ differential\\:\\ 0\\.05229938920568441\ \(0\)\
\-\ clinical\\:\\ 0\\.05101164349481725\ \(0\)\
\-\ diffuse\\:\\ 0\\.050478048976646435\ \(0\)\
\-\ enhancing\\:\\ 0\\.05042303725262154\ \(0\)\
\-\ ultrasound\\:\\ 0\\.049648568165994465\ \(0\)\
\-\ evaluation\\:\\ 0\\.04908815016896478\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04814629663989858\ \(0\)\
\-\ with\\:\\ 0\\.047283646871127946\ \(0\)\
\-\ of\\:\\ 0\\.047255411773853416\ \(0\)\
\-\ 10\\:\\ 0\\.04706726238398013\ \(0\)\
\-\ cm\\:\\ 0\\.04622710418302543\ \(0\)\
\-\ evidence\\:\\ 0\\.04568701952966868\ \(0\)\
\-\ than\\:\\ 0\\.04562826653983097\ \(0\)\
\-\ prior\\:\\ 0\\.045035060313463014\ \(0\)\
\-\ is\\:\\ 0\\.04408621451262089\ \(0\)\
\-\ physical\\:\\ 0\\.043644266040742334\ \(0\)\
\-\ consistent\\:\\ 0\\.043644266040742334\ \(0\)\
\-\ man\\:\\ 0\\.04261312819946789\ \(0\)\
\-\ tumor\\:\\ 0\\.04210165413954499\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04172615328672166\ \(0\)\
\-\ exam\\:\\ 0\\.04051939357010485\ \(0\)\
\-\ large\\:\\ 0\\.04033016961302322\ \(0\)\
\-\ but\\:\\ 0\\.03980310593787076\ \(0\)\
\-\ treatment\\:\\ 0\\.03834230831823583\ \(0\)\
\-\ by\\:\\ 0\\.034181302011461454\ \(0\)\
\-\ the\\:\\ 0\\.0321218879252788\ \(0\)\
\-\ from\\:\\ 0\\.031967757832231124\ \(0\)\
\-\ mass\\:\\ 0\\.030745552823240006\ \(0\)\
\-\ or\\:\\ 0\\.028001512740657562\ \(0\)\
\-\ right\\:\\ 0\\.02668621800665387\ \(0\)\
\-\ on\\:\\ 0\\.024309773943784484\ \(0\)\
